People Inc
For the period ended Sep 30, 2026. Filed Nov 2, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 2, 2026
PPLI$42.08+2.6%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Shareholders' Equity
Three and nine months ended September 30, 2026
| Redeemable Noncontrolling Interests · Common Stock, $0.0001 par value · Class B common stock, $0.0001 par value · Additional Paid-in-Capital · Accumulated Deficit · Accumulated Other Comprehensive Loss · Treasury Stock · Total People IncorporatedShareholders' Equity · NoncontrollingInterests · Total Shareholders’ Equity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ · Shares · $ · Shares | ||||||||||||
| (In thousands) | ||||||||||||
| Balance at June 30, 2026 | $12,236 | $8 | 84,182 | $1 | 5,789 | $6,008,443 | $(208,031) | $(13,763) | $(704,277) | $5,082,381 | $35,507 | $5,117,888 |
| Net earnings (loss) | 1,073 | — | — | — | — | — | (687,491) | — | — | (687,491) | 1,358 | (686,133) |
| Other comprehensive income, net of income taxes | — | — | — | — | — | — | — | 44 | — | 44 | — | 44 |
| Stock-based compensation expense | — | — | — | — | — | 25,082 | — | — | — | 25,082 | — | 25,082 |
| Issuance of common stock pursuant to stock-based awards, net of withholding taxes | — | — | 506 | — | — | (22,889) | — | — | — | (22,889) | — | (22,889) |
| Excise tax on share issuances | — | — | — | — | — | — | — | — | 221 | 221 | — | 221 |
| Payment received pursuant to the tax sharing agreement with Angi Inc. post distribution | — | — | — | — | — | 614 | — | — | — | 614 | — | 614 |
| Adjustment of noncontrolling interests to redemption amount | (1,069) | — | — | — | — | 1,069 | — | — | — | 1,069 | — | 1,069 |
| Adjustment to the liquidation value of Vivian Health preferred shares | — | — | — | — | — | (7,973) | — | — | — | (7,973) | 7,973 | — |
| Other | (211) | — | — | — | — | 51 | — | — | — | 51 | — | 51 |
| Balance at September 30, 2026 | $12,029 | $8 | 84,688 | $1 | 5,789 | $6,004,397 | $(895,522) | $(13,719) | $(704,056) | $4,391,109 | $44,838 | $4,435,947 |
| Balance at December 31, 2025 | $25,264 | $8 | 83,581 | $1 | 5,789 | $5,959,692 | $(643,000) | $(11,842) | $(571,032) | $4,733,827 | $29,932 | $4,763,759 |
| Net earnings (loss) | 1,351 | — | — | — | — | — | (252,522) | — | — | (252,522) | 3,280 | (249,242) |
| Other comprehensive loss, net of income taxes | — | — | — | — | — | — | — | (1,877) | — | (1,877) | — | (1,877) |
| Stock-based compensation expense | — | — | — | — | — | 76,957 | — | — | — | 76,957 | 471 | 77,428 |
| Issuance of common stock pursuant to stock-based awards, net of withholding taxes | — | — | 1,107 | — | — | (42,201) | — | — | — | (42,201) | — | (42,201) |
| Purchase of treasury stock | — | — | — | — | — | — | — | — | (133,024) | (133,024) | — | (133,024) |
| Payment received pursuant to the tax sharing agreement with Angi Inc. post distribution | — | — | — | — | — | 9,105 | — | — | — | 9,105 | — | 9,105 |
| Allocation of certain tax attributes in connection with the Angi Inc. Distribution | — | — | — | — | — | (1,104) | — | — | — | (1,104) | — | (1,104) |
| Adjustment to the Angi Inc. Distribution following the repeal of Canada's digital service tax | — | — | — | — | — | (1,460) | — | — | — | (1,460) | — | (1,460) |
| Adjustment of noncontrolling interests to redemption amount | (14,346) | — | — | — | — | 14,346 | — | — | — | 14,346 | — | 14,346 |
| Adjustment to the liquidation value of Vivian Health preferred shares | — | — | — | — | — | (11,155) | — | — | — | (11,155) | 11,155 | — |
| Other | (240) | — | — | — | — | 217 | — | — | — | 217 | — | 217 |
| Balance at September 30, 2026 | $12,029 | $8 | 84,688 | $1 | 5,789 | $6,004,397 | $(895,522) | $(13,719) | $(704,056) | $4,391,109 | $44,838 | $4,435,947 |
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY
Three and nine months ended September 30, 2025
| Redeemable Noncontrolling Interests · Common Stock, $0.0001 par value · Class B common stock, $0.0001 par value · Additional Paid-in-Capital · Accumulated Deficit · Accumulated Other Comprehensive (Loss) Income · Treasury Stock · Total People Incorporated Shareholders' Equity · NoncontrollingInterests · Total Shareholders’ Equity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ · Shares · $ · Shares | ||||||||||||
| (In thousands) | ||||||||||||
| Balance at June 30, 2025 | $25,279 | $8 | 82,946 | $1 | 5,789 | $5,920,478 | $(544,327) | $(11,102) | $(453,966) | $4,911,092 | $26,411 | $4,937,503 |
| Net earnings (loss) | 156 | — | — | — | — | — | (21,879) | — | — | (21,879) | (14) | (21,893) |
| Other comprehensive loss, net of income taxes | — | — | — | — | — | — | — | (777) | — | (777) | — | (777) |
| Stock-based compensation expense | — | — | — | — | — | 16,639 | — | — | — | 16,639 | 353 | 16,992 |
| Issuance of common stock pursuant to stock-based awards, net of withholding taxes | — | — | 293 | — | — | (12,734) | — | — | — | (12,734) | — | (12,734) |
| Purchase of treasury stock | — | — | — | — | — | — | — | — | (100,882) | (100,882) | — | (100,882) |
| Adjustment of noncontrolling interests to redemption amount | (156) | — | — | — | — | 156 | — | — | — | 156 | — | 156 |
| Adjustment to the liquidation value of Vivian Health preferred shares | — | — | — | — | — | (1,178) | — | — | — | (1,178) | 1,178 | — |
| Other | — | — | — | — | — | 49 | — | — | — | 49 | — | 49 |
| Balance at September 30, 2025 | $25,279 | $8 | 83,239 | $1 | 5,789 | $5,923,410 | $(566,206) | $(11,879) | $(554,848) | $4,790,486 | $27,928 | $4,818,414 |
| Balance at December 31, 2024 | $25,415 | $8 | 84,831 | $1 | 5,789 | $6,380,700 | $(538,974) | $(11,396) | $(252,441) | $5,577,898 | $701,075 | $6,278,973 |
| Net earnings (loss) | 244 | — | — | — | — | — | (27,232) | — | — | (27,232) | 1,316 | (25,916) |
| Other comprehensive (loss) income, net of income taxes | — | — | — | — | — | — | — | (105) | — | (105) | 433 | 328 |
| Stock-based compensation expense | — | — | — | — | — | 13,270 | — | — | — | 13,270 | 2,145 | 15,415 |
| Issuance of common stock pursuant to stock-based awards, net of withholding taxes | — | — | 1,408 | — | — | (57,913) | — | — | — | (57,913) | — | (57,913) |
| Forfeiture of the Company's former CEO's restricted common stock award | — | — | (3,000) | — | — | — | — | — | — | — | — | — |
| Withholding taxes paid on transfer of Angi Inc. Class B shares to the Company's former CEO | — | — | — | — | — | (9,347) | — | — | — | (9,347) | — | (9,347) |
| Issuance of Angi Inc. common stock pursuant to stock-based awards, net of withholding taxes, prior to the Distribution | — | — | — | — | — | (8,264) | — | 4 | — | (8,260) | 3,688 | (4,572) |
| Purchase of treasury stock | — | — | — | — | — | — | — | — | (302,407) | (302,407) | — | (302,407) |
| Purchase of Angi Inc. treasury stock prior to the Distribution | — | — | — | — | — | (10,688) | — | — | — | (10,688) | — | (10,688) |
| Adjustment of noncontrolling interests to redemption amount | (347) | — | — | — | — | 347 | — | — | — | 347 | — | 347 |
| Adjustment to the liquidation value of Vivian Health preferred shares | — | — | — | — | — | (2,198) | — | — | — | (2,198) | 2,198 | — |
| Distribution of the Company's investment in Angi Inc. | — | — | — | — | — | (1,065,612) | — | (382) | — | (1,065,994) | — | (1,065,994) |
| Elimination of Angi Inc. noncontrolling interest | — | — | — | — | — | 682,927 | — | — | — | 682,927 | (682,927) | — |
| Other | (33) | — | — | — | — | 188 | — | — | — | 188 | — | 188 |
| Balance at September 30, 2025 | $25,279 | $8 | 83,239 | $1 | 5,789 | $5,923,410 | $(566,206) | $(11,879) | $(554,848) | $4,790,486 | $27,928 | $4,818,414 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.